Korean AI Sector Expands Into Healthcare and Data Center Infrastructure as iM Securities Upgrades Xi S&D

The Quick Take

• South Korean medical AI firm Lunit showcased diagnostic imaging tools at the 82nd Korean Society of Radiology conference (KCR 2026), engaging clinical professionals across the medical imaging sector
• iM Securities upgraded Xi S&D's growth outlook, citing accelerating AI data center construction orders from both captive GS Group clients and non-captive external clients
• South Korea's AI boom is broadening beyond semiconductors into healthcare diagnostics and physical data center infrastructure construction, expanding the investable opportunity set

South Korea's artificial intelligence sector is demonstrating broader application depth than the globally visible semiconductor segment, with domestic expansion into medical imaging AI and data center infrastructure construction emerging as distinct investable subsectors. Lunit's participation at the KCR 2026 radiology conference with interactive AI diagnostic tools highlights the company's clinical engagement strategy, while iM Securities' growth acceleration thesis for Xi S&D reflects the physical build-out required to support Korea's expanding data center capacity. Both developments signal that Korea's AI-sector investment thesis extends well beyond Samsung Electronics and SK Hynix into second-derivative beneficiaries including specialized builders, software-embedded diagnostics firms, and infrastructure suppliers.

Xi S&D's AI data center order growth represents the infrastructure capex tail of the AI investment supercycle — the semiconductor, software, and cloud layers generate most headlines, but physical construction of data center shells, power systems, and cooling infrastructure is an often-overlooked beneficiary sector. The distinction between captive demand from GS Group-internal projects and non-captive orders from external clients indicates Xi S&D is transitioning from related-party contractor into a competitively positioned infrastructure provider — a re-rating event that typically commands valuation premium from institutional investors. Lunit's hospital conference engagement strategy similarly positions it for broadened customer acquisition beyond current clinical partnerships.

Key monitoring points for Korean AI investment include iM Securities' Xi S&D target price revisions and earnings estimate trajectory, which will quantify the magnitude of the data center opportunity backlog, and any clinical adoption disclosures from Lunit at subsequent radiology or oncology conferences measuring hospital integration rates. The macro variable underlying both stories is global and Korean corporate AI capex — a slowdown in enterprise AI deployment would reduce data center construction backlog and medical AI licensing revenue simultaneously, while sustained capex acceleration extends the growth runway. Investors should also track Samsung SDI and SK Broadband infrastructure orders as corroborating data center demand signals.

Synthesized from 2 sources.